The pharmaceutical industry is undergoing a significant transformation with the adoption of electronic labeling (e-labeling), which replaces traditional paper labels with digital versions accessible via the Internet. This whitepaper explores the implications of e-labeling on Regulatory practices, artwork management, and the overall supply chain. It also examines the benefits, challenges, and global landscape of e-labeling regulations, with a focus on the Asia-Pacific region.
Fill the form below to download the White Paper
